Pharmaids Pharmaceuticals Legal & Regulatory
Pharmaids Pharmaceuticals filed legal complaints against Anugraha Chemicals for dishonoured cheques totalling ₹2.63 Crore in outstanding dues from a disinvestment agreement.
- Value
- ₹2.63 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Pharmaids Pharmaceuticals filed legal complaints against Anugraha Chemicals for dishonoured cheques totalling ₹2.63 Crore in outstanding dues from a disinvestment agreement.
Pharmaids Pharmaceuticals held its 37th AGM via video conference on 11 Sept 2026. Four resolutions including adoption of FY26 financials and related-party-transaction approvals were tabled.
KMP Prasanna Subramanya Bhat acquired 17,291 shares of Pharmaids Pharmaceuticals Ltd via a gift from an immediate relative. This off-market transfer is an insider disclosure.
Pharmaids Pharmaceuticals Limited has issued the notice for its 37th Annual General Meeting, scheduled for September 11, 2026, along with the Annual Report for 2025-26.
Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.1 Cr (-38.8% YoY) and net profit of ₹1.9 Cr (-64.2% YoY) for Q1 FY27.
Pharmaids Pharmaceuticals scheduled a board meeting for August 12, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.